The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics, Inc. | COM | 00461U105 | 7,526 | 429,551 | SH | SOLE | 429,551 | 0 | 0 | ||
Alder BioPharmaceuticals, Inc. | COM | 014339105 | 10,553 | 830,919 | SH | SOLE | 830,919 | 0 | 0 | ||
Alder BioPharmaceuticals, Inc. | COM | 014339955 | 7,900 | 450,000 | SH | Put | SOLE | 450,000 | 0 | 0 | |
Arbutus Biopharma Corporation | COM | 03879J100 | 7,426 | 1,485,245 | SH | SOLE | 1,485,245 | 0 | 0 | ||
Arcus Biosciences, Inc. | COM | 03969F109 | 10,036 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 31,092 | 475,419 | SH | SOLE | 475,419 | 0 | 0 | ||
Biohaven Pharmaceutical Holding Company Ltd. | COM | G11196105 | 21,927 | 851,200 | SH | SOLE | 851,200 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 27,433 | 2,111,869 | SH | SOLE | 2,111,869 | 0 | 0 | ||
Immunomedics, Inc. | COM | 452907108 | 15,681 | 1,073,272 | SH | SOLE | 1,073,272 | 0 | 0 | ||
Insmed Incorporated | COM | 457669307 | 40,519 | 1,799,225 | SH | SOLE | 1,799,225 | 0 | 0 | ||
Insmed Incorporated | COM | 457669957 | 6,800 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | |
Myokardia, Inc. | COM | 62857M105 | 19,127 | 391,955 | SH | SOLE | 391,955 | 0 | 0 | ||
Myokardia, Inc. | COM | 62857M955 | 4,900 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
OptiNose, Inc. | COM | 68404V100 | 9,682 | 483,606 | SH | SOLE | 483,606 | 0 | 0 | ||
Ra Pharmaceuticals, Inc. | COM | 74933V108 | 2,390 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 3,980 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Solid Biosciences Inc. | COM | 83422E105 | 1,052 | 140,332 | SH | SOLE | 140,332 | 0 | 0 | ||
uniQure N.V. | SHS | N90064101 | 13,162 | 560,073 | SH | SOLE | 560,073 | 0 | 0 |